ReviewGenes & diseases2022

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Mehdi Sajjadi-Dokht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.